Back to Search
Start Over
FDA alendronate approval.
- Source :
-
Lancet . 10/14/1995, Vol. 346 Issue 8981, p1028. 1/6p. - Publication Year :
- 1995
-
Abstract
- Reports that the United States' Food and Drug Administration has approved alendronate to treat postmenopausal osteoporosis and Paget's disease. Marketing by Merck and Co as Fosamax; Characteristics of alendronate.
- Subjects :
- *DRUG marketing
Subjects
Details
- Language :
- English
- ISSN :
- 01406736
- Volume :
- 346
- Issue :
- 8981
- Database :
- Academic Search Index
- Journal :
- Lancet
- Publication Type :
- Academic Journal
- Accession number :
- 9510302351
- Full Text :
- https://doi.org/10.1016/S0140-6736(95)91706-3